News 2025
25.11.2025
TBpredict biomarker study launched in Moldova
A new clinical study has begun in the Republic of Moldova to simultaneously test several modern biomarker approaches, aiming to predict treatment response in multidrug-resistant tuberculosis earlier and more accurately—an important step for a country among the world’s highest-incidence regions.
24.11.2025
Launch of the ASTRA Study on Post-Tuberculosis Lung Disease (PTLD) in Albania
The ASTRA study is an international research initiative focused on Post-Tuberculosis Lung Disease (PTLD). The aim of this study is to investigate the health impacts of PTLD on tuberculosis survivors in Albania and to develop solutions to improve their quality of life.
10.11.2025
New guidelines for the treatment of drug-resistant tuberculosis – shorter and better tolerated therapies
Individuals affected by drug-resistant tuberculosis (DR-TB) can now be treated in a significantly shorter and gentler manner. The tuberculosis guideline group for Germany, Austria, and Switzerland has revised its recommendations for treating this severe form of the disease. The revisions are based on the new guidelines issued by the World Health Organization (WHO) in 2025.
